KİMYON, G. Et Al. 2018. Leflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis. ArthritisRheumatology 2018 ACR/ARHP Annual Meeting Abstract Supplement , (United States Of America), 1-3584.

KİMYON, G., KİRAZ, S., ERTENLİ, A. İ., KÜÇÜKŞAHİN, O., DALKILIÇ, H. E., BES, C., ... ALPER KANİTEZ, N.(2018). Leflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis . ArthritisRheumatology 2018 ACR/ARHP Annual Meeting Abstract Supplement (pp.1-3584). , United States Of America

KİMYON, GEZMİŞ Et Al. "Leflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis," ArthritisRheumatology 2018 ACR/ARHP Annual Meeting Abstract Supplement, United States Of America, 2018

KİMYON, GEZMİŞ Et Al. "Leflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis." ArthritisRheumatology 2018 ACR/ARHP Annual Meeting Abstract Supplement , United States Of America, pp.1-3584, 2018

KİMYON, G. Et Al. (2018) . "Leflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis." ArthritisRheumatology 2018 ACR/ARHP Annual Meeting Abstract Supplement , United States Of America, pp.1-3584.

@conferencepaper{conferencepaper, author={GEZMİŞ KİMYON Et Al. }, title={Leflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis}, congress name={ArthritisRheumatology 2018 ACR/ARHP Annual Meeting Abstract Supplement}, city={}, country={United States Of America}, year={2018}, pages={1-3584} }